The New Horizon Talks

Episode 1: New Horizons for Rare Disease Patients


Listen Later

This episode provides an introduction to cell and gene therapies and touches upon the historical, scientific, clinical, policy and regulatory considerations surrounding their development and use, with forward-looking perspectives from our guests on the future of this new chapter of medicine.

Guests:

· Professor Luigi Naldini, Director, San Raffaele Telethon Institute for Gene Therapy

· Avril Daly, Vice-president, Rare Diseases Europe (EURORDIS); CEO, Retina International

----

Abbreviations:

· CAR T cells: chimeric antigen receptor T cells

· HTA: Health technology assessment

...more
View all episodesView all episodes
Download on the App Store

The New Horizon TalksBy CSL Behring